Estonia - Press Releases

VALLEY, Ala., Feb. 14, 2025 /PRNewswire/ --

Offers a Robust Line-Up of Family-Friendly Activities

BALTIMORE, Feb. 15, 2025 /PRNewswire/ -- The National Federation of the Blind strongly condemns the inappropriate and harmful stereotyping of blind people that has been highlighted in the response to a recent Congressional hearing before the House Committee on Oversight and Government Reform Subcommittee on Delivering on Government Efficiency. The online mockery and skepticism directed at a blind witness reflect a broader aggressive and deeply troubling pattern in today's political discourse-one that wrongly assumes blind people, and people with disabilities more generally, lack the capacity to participate fully in public life, including in complex and technical fields. We specifically condemn all media outlets that are actively perpetuating these horrible misconceptions and are falsely validating low expectations that harm our society.

NASDAQ | TSX: ACB

YANTAI, China, Feb. 15, 2025 /PRNewswire/ -- On the morning of February 14, 2025 (UTC-8), at the ongoing 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) held in San Francisco, USA, Professor Xinan Sheng from Peking University Cancer Hospital delivered the latest efficacy and safety data from the phase II clinical trial (NCT05297552, Study ID: RC48-C017) of Disitamab Vedotin (DV) in combination Toripalimab as the neoadjuvant therapy for HER2-expressing muscle-invasive bladder cancer (MIBC) in an oral presentation. This marks the first public disclosure of results from a prospective clinical study investigating an ADC drug in combination with an immunotherapy as a perioperative therapy for MIBC. The pathological complete response (pCR) rate reached an impressive 63.6%, which is a breakthrough improvement compared with traditional neoadjuvant chemotherapies (36%-42%). ASCO GU is one of the top urologic oncology conferences that leading experts worldwide in this field attend.

NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The globalgender reassignment surgery market size is estimated to grow by USD 374.2 million from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of over11.2% during the forecast period. Increase in number of people opting for sex change surgeries globallyis driving market growth,with a trend towardsadvancements in medical technology. However,high cost of surgeries poses a challenge. Key market players include Andrew Ives., Boston Childrens Hospital, Boston Medical Center, Chettawut Plastic Surgery Center, CNY Cosmetic and Reconstructive Surgery, Crane Center, Icahn School of Medicine at Mount Sinai, IVAN MANERO CLINIC S.L., Moein Surgical Arts, Oregon Health and Science University, Phuket International Aesthetic Centre PIAC, Plastic Surgery Group of Rochester, Regents of the University of Michigan, Rumer Cosmetic Surgery, Sava Perovic Foundation Surgery, The Johns Hopkins Health System Corp., Transgender Surgery Institute, and University of Pennsylvania Health System.

VIRGINIA BEACH, Va., Feb. 15, 2025 /PRNewswire/ -- LifeNet Health proudly announces the launch of OraGen, the first viable dental bone allograft comprised of cryopreserved corticocancellous bone containing endogenous lineage-committedbone cells combined with demineralized bone matrix. This unique composition, the core of OraGen's innovation, delivers three essential properties for bone regeneration: osteogenicity, with lineage-committed bone cells that produce new bone; osteoconductivity, providing a biocompatible scaffold for cell attachment and growth; and osteoinduction, which stimulates bone repair through retained natural growth factors.

Bahnbrechende Technologie kombiniert rekombinantes menschliches Kollagen und Hyaluronsure fr sofortige, lang anhaltende Ergebnisse

SUN PRAIRIE, Wis., Feb. 16, 2025 /PRNewswire/ -- Independent Pharmacy Cooperative (IPC),the leading Group Purchasing Organization (GPO) for independent pharmacies nationwide, is thrilled to announce a groundbreaking cooperation agreement with Legacy Pharmacy Group (LPG). This strategic partnership aims to enhance the capabilities and offerings for both organizations, benefiting our members and advancing independent pharmacy.

Revolutionising Vascular Access Care for Critically Ill Newborns and Children

SAN FRANCISCO and SUZHOU, China, Feb. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other major diseases, announced that its first-in-class PD-1/IL-2-bias bispecific antibody fusion protein, IBI363, has received its second Fast Track Designation (FTD) from the U.S. Food and Drug Administration (FDA). This designation applies to the treatment of unresectable, locally advanced, or metastatic squamous non-small cell lung cancer (sqNSCLC) that has progressed following anti-PD-(L)1 immune checkpoint inhibitor therapy and platinum-based chemotherapy. IBI363 has demonstrated encouraging efficacy and safety across multiple solid tumor types. Currently, Innovent is conducting Phase 1/2 clinical trials of IBI363 mainly in China and the U.S.

TAIPEI, Feb. 17, 2025 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announces thethird positive safety review by the independentData and Safety Monitoring Board for its Casppian Phase 3 registration study. The DSMB recommended that Foresee Pharmaceuticalscontinue the trial as planned without any modification.

NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The e-cigarette market in UK and it is set to grow by USD 1.47 billion from 2025 to 2029. However, the growth momentum will progressing at a CAGR of 13.6% during the forecast period, according to Technavio. The e-cigarette market in UK is fragmented, and the vendors are seeking strong partnerships with automotive, industrial, and commercial companies to compete in the market. 1111EC Service Ltd., British American Tobacco Plc, Flavour Warehouse Ltd., Geekvape, Imperial Brands Plc, Innokin Technology Ltd., J WELL France Sarl, Japan Tobacco Inc., LOSTVAPE, Pax Labs Inc., Philip Morris International Inc., RELX International Enterprise HK Ltd., Shenzhen IVPS Technology Co Ltd., SMOORE International Holdings Ltd., and VOOPOO are some of the major market participants -.

CHARLOTTE, N.C., Feb. 14, 2025 /PRNewswire/ -- Honeywell International Inc. (NASDAQ: HON) today announced that its Board of Directors has declared a quarterly dividend payment of $1.13 per share on the Company's common stock. The dividend is payable on March 14, 2025, out of surplus to holders of record at the close of business on February 28, 2025.

CHESAPEAKE, Va., Feb. 14, 2025 /PRNewswire/ -- Greenwave Technology Solutions, Inc. (Nasdaq: GWAV) ("Greenwave" or the "Company"), today announced it was covered by S&P Global Commodity Insights. The interview is available here.

ELGIN, Ill., Feb. 14, 2025 /PRNewswire/ --Anguleris, a global leader in construction technology, has completed the acquisition of Concora Spec, the product specification platform formerly known as SmartBIM.The acquisition will integrate Concora's team, technology, and products with the Anguleris portfolio of brands, further extending Anguleris's global leadership in BIM and specification solutions.

Expanding Equipment Offerings with Industry-Leading Compaction Solutions

SACRAMENTO, Calif., Feb. 14, 2025 /PRNewswire/ -- The Associated General Contractors of California (AGC of California) proudly hosted the sold-out 2025 Installation & Awards Gala, a distinguished black-tie event held at the historic Fairmont Hotel in San Francisco on Friday, Feb. 7. This prestigious event celebrated the exceptional achievements within California's construction industry over the past year and marked the installation of AGC of California's incoming leadership team.

Affordable Granite Concepts customers will see enhanced capabilities and services as a result of the merger with Ally

CHARLOTTE, N.C., Feb. 14, 2025 /PRNewswire/ -- Sealed Air Corporation (NYSE: SEE) announced today that Dustin Semach has been appointed to serve as the President and Chief Executive Officer, effective immediately. Mr. Semach will also serve as a member of the Board of Directors and its Executive Committee.

HUNTINGTON BEACH, Calif., Feb. 14, 2025 /PRNewswire/ -- Karman Holdings Inc. ("Karman" or the "Company"), a company specializing in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs, today announced the closing of its initial public offering of 26,450,000 shares of its common stock at a public offering price of $22.00 per share (the "Common Stock"). The offering consisted of 8,421,053 shares of Common Stock offered by Karman, 14,578,947 shares of Common Stock sold by certain of Karman's existing stockholders (the "Selling Stockholders"), and 3,450,000 additional shares of Common Stock sold by certain Selling Stockholders pursuant to the full exercise of the underwriters' over-allotment option. Karman will not receive any proceeds from the sale of Common Stock by the Selling Stockholders.

Gemcor propose des solutions automatises flexibles pour les applications de forage et de fixation de prcision, alliant une fiabilit prouve une technologie de nouvelle gnration

BIRMINGHAM, Ala., Feb. 14, 2025 /PRNewswire/ --The Board of Directors of Vulcan Materials Company (NYSE:VMC) today declared a quarterly cash dividend of $0.49 per share on its common stock. The dividend will be payable on March 24, 2025, to shareholders of record at the close of business on March 10, 2025. The new quarterly dividend represents an increase of 7 percent from $0.46 to $0.49 per share.

First-of-Its-Kind Gated Neighborhood Brings Modern Housing, Resort-Style Amenities, and Community-Focused Living to the Central Coast

WASHINGTON, Feb. 14, 2025 /PRNewswire/ -- With a suite of NASA science and technology on board, Firefly Aerospace is targeting no earlier than 3:45 a.m. EST on Sunday, March 2, to land the Blue Ghost lunar lander on the Moon. Blue Ghost is slated to touch down near Mare Crisium, a plain in the northeast quadrant on the near side of the Moon, as part of NASA's CLPS (Commercial Lunar Payload Services) initiative and Artemis campaign to establish a long-term lunar presence.